Page last updated: 2024-09-03

1,25-dihydroxyergocalciferol and Cirrhosis

1,25-dihydroxyergocalciferol has been researched along with Cirrhosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brennan, EP; Cullen, C; Godson, C; Nolan, KA; Ryan, A; Scholz, CC; Taylor, CT1

Other Studies

1 other study(ies) available for 1,25-dihydroxyergocalciferol and Cirrhosis

ArticleYear
Paricalcitol protects against TGF-β1-induced fibrotic responses in hypoxia and stabilises HIF-α in renal epithelia.
    Experimental cell research, 2015, Jan-15, Volume: 330, Issue:2

    Topics: Actins; Basic Helix-Loop-Helix Transcription Factors; Cadherins; Calcium-Binding Proteins; Cell Hypoxia; Cell Line, Transformed; Epithelial Cells; Ergocalciferols; Fibrosis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Intercellular Signaling Peptides and Proteins; Jagged-1 Protein; Kidney; Membrane Proteins; Nephritis, Interstitial; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Stability; RNA Interference; Serrate-Jagged Proteins; Smad2 Protein; Thrombospondin 1; Transforming Growth Factor beta1

2015